These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 8080866)
1. [3 new cases of Enterobacter taylorae infection]. Martínez J; Toval M; Colomo LF Enferm Infecc Microbiol Clin; 1994; 12(6):289-92. PubMed ID: 8080866 [TBL] [Abstract][Full Text] [Related]
2. Enterobacter bacteremia: Clinical features, risk factors for multiresistance and mortality in a Chinese University Hospital. Ye Y; Li JB; Ye DQ; Jiang ZJ Infection; 2006 Oct; 34(5):252-7. PubMed ID: 17033748 [TBL] [Abstract][Full Text] [Related]
3. Pneumonia due to Enterobacter cancerogenus infection. Demir T; Baran G; Buyukguclu T; Sezgin FM; Kaymaz H Folia Microbiol (Praha); 2014 Nov; 59(6):527-30. PubMed ID: 24973962 [TBL] [Abstract][Full Text] [Related]
5. [Human infections caused by Enterobacter taylorae: report of 6 cases]. Reina J; Alomar P Rev Clin Esp; 1992 Nov; 191(7):394-5. PubMed ID: 1475470 [No Abstract] [Full Text] [Related]
6. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study. Deal EN; Micek ST; Reichley RM; Ritchie DJ Clin Ther; 2009 Feb; 31(2):299-310. PubMed ID: 19302902 [TBL] [Abstract][Full Text] [Related]
7. Enterobacter taylorae, a new opportunistic pathogen: report of four cases. Rubinstien EM; Klevjer-Anderson P; Smith CA; Drouin MT; Patterson JE J Clin Microbiol; 1993 Feb; 31(2):249-54. PubMed ID: 8381808 [TBL] [Abstract][Full Text] [Related]
8. [Nosocomial infections with resistant Enterobacter cloacae. Effects on the disease and the treatment]. Olafsen K; Hotvedt R; Andersen BM; Almdahl SM; Sørlie D Tidsskr Nor Laegeforen; 1989 Jan; 109(3):332-6. PubMed ID: 2916217 [TBL] [Abstract][Full Text] [Related]
9. Bloodstream infections caused by Enterobacter species: predictors of 30-day mortality rate and impact of broad-spectrum cephalosporin resistance on outcome. Kang CI; Kim SH; Park WB; Lee KD; Kim HB; Oh MD; Kim EC; Choe KW Clin Infect Dis; 2004 Sep; 39(6):812-8. PubMed ID: 15472813 [TBL] [Abstract][Full Text] [Related]
10. Clinical characteristics and risk factors for attributable mortality in Enterobacter cloacae bacteremia. Lin YC; Chen TL; Ju HL; Chen HS; Wang FD; Yu KW; Liu CY J Microbiol Immunol Infect; 2006 Feb; 39(1):67-72. PubMed ID: 16440126 [TBL] [Abstract][Full Text] [Related]
11. [Nosocomial bacteremia caused by Enterobacter spp.: epidemiology and prognostic factors]. Peña C; Pujol M; Pallarés R; Cisnal M; Ariza J; Gudiol F Enferm Infecc Microbiol Clin; 1993 Oct; 11(8):424-8. PubMed ID: 8260514 [TBL] [Abstract][Full Text] [Related]
12. Changing pattern of neonatal bacteremia. Microbiology and antibiotic resistance. Ellabib MS; Ordonez A; Ramali A; Walli A; Benayad T; Shebrlo H Saudi Med J; 2004 Dec; 25(12):1951-6. PubMed ID: 15711674 [TBL] [Abstract][Full Text] [Related]
18. Impact of previous use of antibiotics on development of resistance to extended-spectrum cephalosporins in patients with enterobacter bacteremia. Lee SO; Kim YS; Kim BN; Kim MN; Woo JH; Ryu J Eur J Clin Microbiol Infect Dis; 2002 Aug; 21(8):577-81. PubMed ID: 12226687 [TBL] [Abstract][Full Text] [Related]